Cargando…

M2pep-Modified Cyclodextrin-siRNA Nanoparticles Modulate the Immunosuppressive Tumor Microenvironment for Prostate Cancer Therapy

[Image: see text] Prostate cancer (PCa) is the most prevalent cause of cancer deaths in men. Conventional strategies, such as surgery, radiation, or chemotherapy, face challenges including poor prognosis and resistance. Therefore, the development of new improved strategies is vital to enhance patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yao, Cronin, Michael F., Mendonça, Monique C. P., Guo, Jianfeng, O’Driscoll, Caitriona M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630955/ https://www.ncbi.nlm.nih.gov/pubmed/37874541 http://dx.doi.org/10.1021/acs.molpharmaceut.3c00769

Ejemplares similares

Co-Formulation of Amphiphilic Cationic and Anionic Cyclodextrins Forming Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukaemia
por: Kont, Ayse, et al.
Publicado: (2022)

Cyclodextrin-Based Nanoparticles for Delivery of Antisense Oligonucleotides Targeting Huntingtin
por: Mendonça, Monique C. P., et al.
Publicado: (2023)

Cationic and PEGylated Amphiphilic Cyclodextrins: Co-Formulation Opportunities for Neuronal Sirna Delivery
por: O’Mahony, Aoife M., et al.
Publicado: (2013)

Tetraethylenepentamine-Coated β Cyclodextrin Nanoparticles for Dual DNA and siRNA Delivery
por: Liu, Chi-Hsien, et al.
Publicado: (2022)

Cyclodextrin and Polyethylenimine Functionalized Mesoporous Silica Nanoparticles for Delivery of siRNA Cancer Therapeutics
por: Shen, Jianliang, et al.
Publicado: (2014)

Poly(ethylene glycol)-Based Peptidomimetic “PEGtide” of Oligo-Arginine Allows for Efficient siRNA Transfection and Gene Inhibition
por: Hibbitts, Alan, et al.
Publicado: (2019)

Lipid nanoparticle-encapsulated, chemically modified anti-adenoviral siRNAs inhibit hepatic adenovirus infection in immunosuppressed Syrian hamsters
por: Geisler, Anja, et al.
Publicado: (2023)

Characterization of modified mesoporous silica nanoparticles as vectors for siRNA delivery
por: Slita, Anna, et al.
Publicado: (2018)

Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014)

Potential Use of Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for siRNA
por: Arima, Hidetoshi, et al.
Publicado: (2011)

Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment
por: Xu, Zhenghong, et al.
Publicado: (2014)

Gold nanoparticles enlighten the future of cancer theranostics
por: Guo, Jianfeng, et al.
Publicado: (2017)

Enhanced Delivery of Therapeutic siRNA into Glioblastoma Cells Using Dendrimer-Entrapped Gold Nanoparticles Conjugated with β-Cyclodextrin
por: Qiu, Jieru, et al.
Publicado: (2018)

A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer
por: Sun, Dandan, et al.
Publicado: (2022)

A β-Cyclodextrin-Based Nanoparticle with Very High Transfection Efficiency Unveils siRNA-Activated TLR3 Responses in Human Prostate Cancer Cells
por: de la Torre, Cristina, et al.
Publicado: (2022)

Silver Nanoparticles Surface-Modified with Carbosilane Dendrons as Carriers of Anticancer siRNA
por: Pędziwiatr-Werbicka, Elżbieta, et al.
Publicado: (2020)

Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for DNA, shRNA and siRNA
por: Arima, Hidetoshi, et al.
Publicado: (2012)

Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles
por: Ballarín-González, Borja, et al.
Publicado: (2013)

Cyclodextrin-Based Nanostructure Efficiently Delivers siRNA to Glioblastoma Cells Preferentially via Macropinocytosis
por: Manzanares, Darío, et al.
Publicado: (2020)

A Fresh Look at the Potential of Cyclodextrins for Improving the Delivery of siRNA Encapsulated in Liposome Nanocarriers
por: Castillo Cruz, Betzaida, et al.
Publicado: (2022)

Albumin pre-coating enhances intracellular siRNA delivery of multifunctional amphiphile/siRNA nanoparticles
por: Kummitha, China M, et al.
Publicado: (2012)

Advances in Lipid Nanoparticles for siRNA Delivery
por: Tam, Yuen Yi C., et al.
Publicado: (2013)

BSA Nanoparticles for siRNA Delivery: Coating Effects on Nanoparticle Properties, Plasma Protein Adsorption, and In Vitro siRNA Delivery
por: Yogasundaram, Haran, et al.
Publicado: (2012)

Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System
por: Mendonça, Monique C. P., et al.
Publicado: (2021)

Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo
por: EL Andaloussi, Samir, et al.
Publicado: (2011)

siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy
por: Xia, Yu, et al.
Publicado: (2018)

Polymeric Nanoparticles Based on Tyrosine-Modified, Low Molecular Weight Polyethylenimines for siRNA Delivery
por: Ewe, Alexander, et al.
Publicado: (2019)

siRNAmod: A database of experimentally validated chemically modified siRNAs
por: Dar, Showkat Ahmad, et al.
Publicado: (2016)

Intracellular Delivery of siRNA by Polycationic Superparamagnetic Nanoparticles
por: Castillo, Betzaida, et al.
Publicado: (2012)

ECO/siRNA nanoparticles and breast cancer metastasis
por: Lu, Zheng-Rong, et al.
Publicado: (2015)

Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy
por: Ben-David-Naim, Meital, et al.
Publicado: (2019)

Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA
por: Li, Jin-Ming, et al.
Publicado: (2013)

Targeted delivery of HES5-siRNA with novel polypeptide-modified nanoparticles for hepatocellular carcinoma therapy
por: Xia, Yu, et al.
Publicado: (2018)

Aptamer-siRNA chimera and gold nanoparticle modified collagen membrane for the treatment of malignant pleural effusion
por: Chen, Wen, et al.
Publicado: (2022)

Harnessing the potential of lipid nanoparticles for the delivery of chemically modified siRNA to combat hepatic adenovirus infection
por: Shubhra, Quazi T.H., et al.
Publicado: (2023)

Inhibition of MDR1 expression with altritol-modified siRNAs
por: Fisher, Michael, et al.
Publicado: (2007)

Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing
por: Vollmann, Elisabeth H., et al.
Publicado: (2017)

Effect of the amount of cationic lipid used to complex siRNA on the cytotoxicity and proinflammatory activity of siRNA-solid lipid nanoparticles
por: Hanafy, Mahmoud S., et al.
Publicado: (2023)

Calcium phosphate nanoparticles-based systems for siRNA delivery
por: Xu, Xiaochun, et al.
Publicado: (2016)

Cationic Magnetite Nanoparticles for Increasing siRNA Hybridization Rates
por: Prilepskii, Artur Y., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kt4uaa86ettbl5p0taqqhsn31k